Connection

Solange Peters to B7-H1 Antigen

Back to Details
This is a "connection" page, showing publications Solange Peters has written about B7-H1 Antigen.
Solange Peters
Connection Strength
0.452
B7-H1 Antigen
  1. 18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2019 Aug; 46(9):1859-1868.
    View in: PubMed
    Score: 0.147
  2. Delineating the Role of PD-1/PD-L1 Blockade in Advanced SCLC. J Thorac Oncol. 2018 09; 13(9):1242-1244.
    View in: PubMed
    Score: 0.139
  3. Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH). J Clin Oncol. 2017 Aug 20; 35(24):2781-2789.
    View in: PubMed
    Score: 0.128
  4. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2019 11 21; 381(21):2020-2031.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.